title: Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.
abstract: Sphingosine-1-phosphate receptors (S1P1-5) are activated by the endogenous agonist S1P and are expressed in the central nervous system. In astrocytes, activation of S1P receptors leads to phosphorylation of extracellular-signal regulated kinase (ERK), a signaling cascade which plays intimate roles in cell proliferation. Fingolimod (FTY720) is in phase III clinical trials for the treatment of multiple sclerosis and its phosphorylated version (FTY720P) activates S1P receptors. We examined the effects of FTY720P on ERK phosphorylation and determined which S1P receptor subtype(s) mediated this signaling event. FTY720P augmented ERK phosphorylation in cortical cultures prepared from embryonic day 18 rat brains and was blocked by an MEK inhibitor or by pertussis toxin. Co-localisation of phosphorylated ERK occurred in glial fibrillary acidic protein (GFAP) positive astrocytes but not neurons or oligodendrocytes. Furthermore, FTY720P stimulated ERK phosphorylation in highly enriched astrocyte cultures made from postnatal day 2 rat cortices. The effects of FTY720P were mimicked by selective S1P1 receptor agonists and blocked by S1P1 receptor antagonists. Collectively, these results demonstrate that FTY720P mediates ERK phosphorylation in astrocytes via the activation of S1P1 receptors.
authors: Department of Neuroscience, Novartis Institutes for BioMedical Research, Unit of Neurodegeneration, Novartis Pharma, WSJ-386.7.43 Lichtstrasse 35, CH-4002 Basel, Switzerland.
authors: Maribel
authors: M
authors: Osinde
authors: Florian
authors: F
authors: Mullershausen
authors: Kumlesh K
authors: KK
authors: Dev
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism*; D015153:Blotting, Western; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D005260:Female; D000068876:Fingolimod Hydrochloride; D019206:GTP-Binding Protein alpha Subunits, Gi-Go / Q000378:metabolism; D007150:Immunohistochemistry; D037342:Pertussis Toxin / Q000494:pharmacology; D010766:Phosphorylation; D011247:Pregnancy; D011409:Propylene Glycols / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D049349:Receptors, Lysosphingolipid / Q000187:drug effects*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D011409:Propylene Glycols; D049349:Receptors, Lysosphingolipid; D037342:Pertussis Toxin; D048049:Extracellular Signal-Regulated MAP Kinases; D019206:GTP-Binding Protein alpha Subunits, Gi-Go; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine